Pharmacological Targets for Correction of Dyslipidemias. Opportunities and Prospects of Therapeutic Use


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

The review summarizes literature data on existing pharmacological agents and novel drug preparations developed for correction of dyslipidemias and molecular mechanisms of their action. Much attention is paid to analysis of experimental and clinical studies aimed at identification of new pharmacological targets for correction of dyslipidemias and characterization of approaches increasing high density lipoproteins functionality. The implementation of alternative pharmacological agents with new alternative mechanisms of action may improve the effectiveness of traditional treatment in the future.

Sobre autores

V. Kudinov

Institute of Biomedical Chemistry (IBMC)

Email: tz-post@list.ru
Rússia, ul. Pogodinskaya 10, Moscow, 119121

T. Zakharova

Institute of Biomedical Chemistry (IBMC)

Autor responsável pela correspondência
Email: tz-post@list.ru
Rússia, ul. Pogodinskaya 10, Moscow, 119121

T. Torkhovskaya

Institute of Biomedical Chemistry (IBMC)

Email: tz-post@list.ru
Rússia, ul. Pogodinskaya 10, Moscow, 119121

O. Ipatova

Institute of Biomedical Chemistry (IBMC)

Email: tz-post@list.ru
Rússia, ul. Pogodinskaya 10, Moscow, 119121

A. Archakov

Institute of Biomedical Chemistry (IBMC)

Email: tz-post@list.ru
Rússia, ul. Pogodinskaya 10, Moscow, 119121

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Pleiades Publishing, Ltd., 2018